Queen Mary University of London

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Queen Mary University of London (or QMUL) is a university in London, England, UK. Its main campus is in Mile End in East London.[1] The university was the home of the principal investigator of the PACE trial, Peter White.

ME/CFS Research[edit | edit source]

Professor Peter White was principle investigator for the controversial PACE trial, and first author of the main PACE trial outcome study. QMUL spent approximately £250,000 unsuccessfully attempting to prevent the release of anonymized PACE trial data under the Freedom of Information Act law.

Wolfson Institute for Preventative Medicine[edit | edit source]

The Wolfson Institute for Preventative Medicine consists of Queen Mary University's Institute of Psychiatry plus two other research departments.[2] After the PACE trial research was completed, the Wolfson Institute removed the majority of the PACE trial documentation, although some remains.

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]